Xarelto

Bayer HealthCare has launched Xarelto (rivaroxaban) for the prevention of venous thromboembolism in adult patients undergoing elective hip or knee replacement surgery.

by

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package